Indication
Invasive Fungal Infections
11 clinical trials
15 products
Product
RezafunginClinical trial
A Phase 1, Multicentre, Open-Label Study to Evaluate the PK, Safety, and Tolerability of a Single IV Dose of Rezafungin in Paediatric Subjects, Receiving Systemic Antifungals as Prophylaxis for IFI or to Treat a Suspected or Confirmed FIStatus: Recruiting, Estimated PCD: 2027-03-01
Clinical trial
A Phase 2, Open-Label Study to Evaluate the Safety and Efficacy of APX001 in the Treatment of Patients With Invasive Mold Infections Caused by Aspergillus Species or Rare MoldsStatus: Terminated, Estimated PCD: 2022-03-29
Product
fosmanogepixClinical trial
A Phase 1, Double-blinded, Placebo-controlled Study to Assess the Safety, Tolerability, and Pharmacokinetics of BSG005 Following Single and Multiple Ascending Doses in Healthy SubjectsStatus: Recruiting, Estimated PCD: 2023-03-01
Product
BSG005Product
AmBisomeProduct
DKF-5122Clinical trial
Bioequivalence Study to Evaluate Pharmacokinetics and Safety of AmBisome and DKF-5122 in Indicated Patients and Healthy AdultsStatus: Completed, Estimated PCD: 2022-01-28
Clinical trial
Phase IIb Study of F901318 as Treatment of Invasive Fungal Infections Due to Lomentospora Prolificans, Scedosporium Spp., Aspergillus Spp., and Other Resistant Fungi in Patients Lacking Suitable Alternative Treatment OptionsStatus: Recruiting, Estimated PCD: 2022-09-02
Product
F901318Clinical trial
Phase 1 Biodistribution and Pathophysiology Study of 18F-Fluorodeoxysorbitol (18F-FDS)Status: Recruiting, Estimated PCD: 2025-05-31
Product
18F-FDS PET/CTClinical trial
Micafungin Versus Amphotercine B in Treatment of Invasive Fungal Infection In Preterm Neonates: A Randomized Control TrialStatus: Completed, Estimated PCD: 2023-05-20
Product
MicafunginProduct
Amphotericin BClinical trial
A 3-Treatment, 3-Period, 6-Sequence Randomized Crossover Single-Dose Study Evaluating the Bioequivalence of High-Load and Low-Load Oral Tablet Formulations of Apx001 and the Effect of Food on the Absorption of Apx001 From the High-Load Tablet In Healthy SubjectsStatus: Completed, Estimated PCD: 2021-05-13
Product
APX001Product
APX001AClinical trial
Population Pharmacokinetics and Dose Optimization of Caspofungin in Adolescents With Allogeneic Hematopoietic Stem Cell TransplantationStatus: Completed, Estimated PCD: 2019-03-03
Product
CaspogunfinClinical trial
SUBA-itraconazole Versus Conventional Itraconazole in the Treatment of Endemic Mycoses: a Multi-center, Open-label Comparative TrialStatus: Completed, Estimated PCD: 2021-05-31
Product
SUBA itraconazoleProduct
ItraconazoleClinical trial
Expanded Access to Fosmanogepix for Patients With Serious or Life-threatening Invasive Fungal Infections Who Have no Other Treatment OptionsStatus:
Product
Fosmanogepix